NCT03594773 Modeling Multi-level Dyadic Behavior to Transform the Science and Practice of Psychotherapy Process and Outcome. Status COMPLETED Phase NA
NCT03591224 Pharmacogenomic Testing to Optimize Antidepressant Drug Therapy Status COMPLETED Phase NA
NCT03580967 Vortioxetine Monotherapy for Major Depressive Disorder in Type 2 Diabetes Status WITHDRAWN Phase PHASE4
NCT03573349 Ketamine Associated ACC GABA and Glutamate Change and Depression Remission: Status ACTIVE_NOT_RECRUITING Phase EARLY_PHASE1
NCT03571412 Antidepressive Effect on 5 Herz (Hz) rTMS Over Dorsomedial Prefrontal Cortex and Left Dorsolateral Prefrontal Cortex Status COMPLETED Phase NA
NCT03569475 Efficacy, Safety, and Tolerability of Levomilnacipran ER in Pediatric Patients (7-17 Years) With Major Depressive Disorder Status COMPLETED Phase PHASE3
NCT03558256 The Study of Mindfulness-based Cognitive Therapy and Major Depressive Disorder Status UNKNOWN Phase NA
NCT03554447 Role of Pentoxifylline as an Adjuvant Therapy for Adult Patients With Major Depressive Disorder Status COMPLETED Phase NA
NCT03554174 Psilocybin - Induced Neuroplasticity in the Treatment of Major Depressive Disorder Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT03551288 Effect of Food, Gender, and Age on the Pharmacokinetic Profile of SUVN-911 in Healthy Subjects Status COMPLETED Phase PHASE1
NCT03548545 tDCS as add-on Treatment to Cognitive-Behavior Therapy in People With MDD Status UNKNOWN Phase NA
NCT03538691 A Trial to Evaluate the Efficacy, Safety & Tolerability of Brexpiprazole in the Maintenance Treatment of Adults With Major Depressive Disorder Status COMPLETED Phase PHASE3
NCT03537547 Combinatorial Pharmacogenomics Testing in Treatment-Naïve Major Depressive Disorder Status TERMINATED Phase PHASE4
NCT03523767 Effect of Systemic Inflammation on Emotion and Cognition in Patients With Mood Disorder - A Vaccine Study Status TERMINATED Phase PHASE1
NCT03514810 Combined Sertraline and Ketoprofen Administration in Major Depressive Disorder Status COMPLETED Phase PHASE1